Search

Your search keyword '"Gardini, Andrea Casadei"' showing total 25 results

Search Constraints

Start Over You searched for: Author "Gardini, Andrea Casadei" Remove constraint Author: "Gardini, Andrea Casadei" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
25 results on '"Gardini, Andrea Casadei"'

Search Results

2. Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

3. A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

5. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

6. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

7. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.

8. Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy.

9. Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments

10. Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

11. Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib

13. Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes.

14. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

15. The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis

16. Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis

17. Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma

18. THU-145 - Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments

19. THU-131 - Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib

21. LBO-04 - Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma

23. SAT180 - The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis

24. FRI554 - Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis

25. FRI222 - Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma

Catalog

Books, media, physical & digital resources